CEO ULISSES DS (The Collider Programme)
ULISSES DS | Standardizing the future of ultrasound imaging
CEO & Co-Founder Opportunity | HealthTech | AI | Medical Imaging
Are you ready to build a high-impact HealthTech spin-off transforming ultrasound diagnostics through artificial intelligence?
ULISSES DS is a medical software that standardizes ultrasound images, enabling reproducible digital analysis and unlocking the full potential of AI in ultrasonography. The project has demonstrated strong diagnostic performance and is preparing for spin-off creation and regulatory advancement.
We are seeking an entrepreneurial CEO to lead company formation, regulatory strategy, commercialization, and fundraising.
About ULISSES DS
Ultrasound is widely used across all medical specialties because it is safe, affordable, and allows for real-time evaluation. However, its high technical variability has prevented reproducible digital image analysis and the development of robust AI models. This limitation leads to subjective interpretation, diagnostic uncertainty, and thousands of unnecessary invasive procedures each year.
ULISSES standardizes ultrasound images across scanners and acquisition settings, minimizing variability and enabling reproducible extraction of radiomic features, faster and more efficient AI model training and improved diagnostic performance, even with small datasets. The methodology is organ-agnostic, with initial applications in thyroid and breast imaging.
Why ULISSES DS
Demonstrated diagnostic performance with AUC > 90% in breast ultrasound modelsSolves the key technical bottleneck limiting scalable AI in ultrasoundEnables faster, cheaper and more accurate AI developmentPotential to spare thousands of unnecessary invasive procedures yearlyClear roadmap and a multidisciplinary team combining clinical insight, biomedical engineering and AI/software expertise.
Current Founding Team
Dr. Pablo Valderrábano – Principal InvestigatorPaula Quintana – Future COOAlejandro García - Future CTO
Your Role as CEO & Co-Founder (Next 6 Months)
You will lead ULISSES through a critical transition phase:
Spin-off creation and shareholder structuringDefinition of regulatory pathway (CE marking for medical software)Business model validation (B2B hospitals PACS integration)Early hospital pilots and commercial validationFundraising strategy (public & private capital)Positioning within AI-driven medical imaging ecosystem
The Offer
Relevant equity as CEO & Co-Founder upon company incorporation€6,000 stipend during validation phase (3 monthly instalments of €2,000)Opportunity to access a participative loan of up to €50,000Access to The Collider venture-building programme, including regulatory, AI and HealthTech mentors, IP and fundraising specialists, support in spin-off creation and shareholder agreement.International exposure (4YFN, MWC, corporate & investor networks)Coworking space in Barcelona (Tech Barcelona – Pier 01)Two years of post-incorporation venture-builder support, including in-kind services, community access and portfolio perks.
This Opportunity Is for You If
You are an entrepreneur with experience in HealthTech, AI, medical imaging or digital healthPrevious founder/co-founder experienceFamiliar with medical device regulation and CE markingExperience in hospital sales cycles or B2B SaaSComfortable bridging clinical validation, AI productization and commercializationInterested in scalable software platformsEligible to work in SpainFluent in English and Spanish
Apply Now
CEO & Co-Founder Opportunity | HealthTech | AI | Medical Imaging
Are you ready to build a high-impact HealthTech spin-off transforming ultrasound diagnostics through artificial intelligence?
ULISSES DS is a medical software that standardizes ultrasound images, enabling reproducible digital analysis and unlocking the full potential of AI in ultrasonography. The project has demonstrated strong diagnostic performance and is preparing for spin-off creation and regulatory advancement.
We are seeking an entrepreneurial CEO to lead company formation, regulatory strategy, commercialization, and fundraising.
About ULISSES DS
Ultrasound is widely used across all medical specialties because it is safe, affordable, and allows for real-time evaluation. However, its high technical variability has prevented reproducible digital image analysis and the development of robust AI models. This limitation leads to subjective interpretation, diagnostic uncertainty, and thousands of unnecessary invasive procedures each year.
ULISSES standardizes ultrasound images across scanners and acquisition settings, minimizing variability and enabling reproducible extraction of radiomic features, faster and more efficient AI model training and improved diagnostic performance, even with small datasets. The methodology is organ-agnostic, with initial applications in thyroid and breast imaging.
Why ULISSES DS
Demonstrated diagnostic performance with AUC > 90% in breast ultrasound modelsSolves the key technical bottleneck limiting scalable AI in ultrasoundEnables faster, cheaper and more accurate AI developmentPotential to spare thousands of unnecessary invasive procedures yearlyClear roadmap and a multidisciplinary team combining clinical insight, biomedical engineering and AI/software expertise.
Current Founding Team
Dr. Pablo Valderrábano – Principal InvestigatorPaula Quintana – Future COOAlejandro García - Future CTO
Your Role as CEO & Co-Founder (Next 6 Months)
You will lead ULISSES through a critical transition phase:
Spin-off creation and shareholder structuringDefinition of regulatory pathway (CE marking for medical software)Business model validation (B2B hospitals PACS integration)Early hospital pilots and commercial validationFundraising strategy (public & private capital)Positioning within AI-driven medical imaging ecosystem
The Offer
Relevant equity as CEO & Co-Founder upon company incorporation€6,000 stipend during validation phase (3 monthly instalments of €2,000)Opportunity to access a participative loan of up to €50,000Access to The Collider venture-building programme, including regulatory, AI and HealthTech mentors, IP and fundraising specialists, support in spin-off creation and shareholder agreement.International exposure (4YFN, MWC, corporate & investor networks)Coworking space in Barcelona (Tech Barcelona – Pier 01)Two years of post-incorporation venture-builder support, including in-kind services, community access and portfolio perks.
This Opportunity Is for You If
You are an entrepreneur with experience in HealthTech, AI, medical imaging or digital healthPrevious founder/co-founder experienceFamiliar with medical device regulation and CE markingExperience in hospital sales cycles or B2B SaaSComfortable bridging clinical validation, AI productization and commercializationInterested in scalable software platformsEligible to work in SpainFluent in English and Spanish
Apply Now